Peter Kühnen, Jesús Argente, Karine Clément, Hélène Dollfus, Béatrice Dubern, Sadaf Farooqi, Corjan de Groot, Annette Grüters, Jens-Christian Holm, Mark Hopkins, Lotte Kleinendorst, Antje Körner, David Meeker, Mikael Rydén, Julia von Schnurbein, Matthias Tschöp, Giles S H Yeo, Stefanie Zorn, Martin Wabitsch
Nearly 90 clinicians and researchers from around the world attended the first IMPROVE 2022 International Meeting on Pathway-Related Obesity. Delegates attended in person or online from across Europe, Argentina and Israel to hear the latest scientific and clinical developments in hyperphagia and severe, early-onset obesity, and set out a vision of excellence for the future for improving the diagnosis, treatment, and care of patients with melanocortin-4 receptor (MC4R) pathway-related obesity. The meeting co-chair Peter Kühnen, Charité Universitätsmedizin Berlin, Germany, indicated that change was needed with the rapidly increasing prevalence of obesity and the associated complications to improve the understanding of the underlying mechanisms and acknowledge that monogenic forms of obesity can play an important role, providing insights that can be applied to a wider group of patients with obesity...
April 11, 2024: Clinical Obesity